Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
College of Nursing and Health, Henan University, Kaifeng, Henan, China.
Glob Health Res Policy. 2022 Apr 29;7(1):12. doi: 10.1186/s41256-022-00245-3.
With the continuation of the COVID-19 pandemic, some COVID-19 patients have become reinfected with the virus. Viral gene sequencing has found that some of these patients were reinfected by the different and others by same strains. This has raised concerns about the effectiveness of immunity after infection and the reliability of vaccines. To this end, we conducted a systematic review to assess the characteristics of patients with reinfection and possible causes.
A systematic search was conducted across eight databases: PubMed, Embase, Web of Science, The Cochrane Library, CNKI, WanFang, VIP and SinoMed from December 1, 2019 to September 1, 2021. The quality of included studies were assessed using JBI critical appraisal tools and Newcastle-Ottawa Scale.
This study included 50 studies from 20 countries. There were 118 cases of reinfection. Twenty-five patients were reported to have at least one complication. The shortest duration between the first infection and reinfection was 19 days and the longest was 293 days. During the first infection and reinfection, cough (51.6% and 43.9%) and fever (50% and 30.3%) were the most common symptoms respectively. Nine patients recovered, seven patients died, and five patients were hospitalized, but 97 patients' prognosis were unknown. B.1 is the most common variant strain at the first infection. B.1.1.7, B.1.128 and B.1.351 were the most common variant strains at reinfection. Thirty-three patients were infected by different strains and 9 patients were reported as being infected with the same strain.
Our research shows that it is possible for rehabilitated patients to be reinfected by SARS-COV-2. To date, the causes and risk factors of COVID-19 reinfection are not fully understood. For patients with reinfection, the diagnosis and management should be consistent with the treatment of the first infection. The public, including rehabilitated patients, should be fully vaccinated, wear masks in public places, and pay attention to maintaining social distance to avoid reinfection with the virus.
随着 COVID-19 大流行的持续,一些 COVID-19 患者再次感染了该病毒。病毒基因测序发现,其中一些患者是被不同的毒株再次感染,而另一些则是被同一毒株再次感染。这引发了人们对感染后免疫效果和疫苗可靠性的担忧。为此,我们进行了一项系统综述,以评估再次感染患者的特征和可能的原因。
我们在 2019 年 12 月 1 日至 2021 年 9 月 1 日期间,在 8 个数据库(PubMed、Embase、Web of Science、The Cochrane Library、CNKI、万方、维普及中国生物医学文献数据库)中进行了系统检索。使用 JBI 批判性评价工具和纽卡斯尔-渥太华量表评估纳入研究的质量。
本研究纳入了来自 20 个国家的 50 项研究,共 118 例再感染病例。报告了 25 例至少有一种并发症的患者。首次感染和再感染之间的最短时间间隔为 19 天,最长时间间隔为 293 天。在首次感染和再感染期间,最常见的症状分别是咳嗽(51.6%和 43.9%)和发热(50%和 30.3%)。9 例患者康复,7 例患者死亡,5 例患者住院,但 97 例患者的预后情况未知。B.1 是首次感染中最常见的变异株,B.1.1.7、B.1.128 和 B.1.351 是再感染中最常见的变异株。33 例患者被不同的毒株感染,9 例患者被报告为感染同一毒株。
我们的研究表明,康复患者有可能再次感染 SARS-COV-2。迄今为止,COVID-19 再次感染的原因和危险因素尚未完全清楚。对于再次感染的患者,其诊断和管理应与首次感染的治疗一致。包括康复患者在内的公众应充分接种疫苗,在公共场所佩戴口罩,注意保持社交距离,以避免再次感染该病毒。